Effects of Different Exercise Types on Irisin, Leptin, and Ghrelin Levels in Sedentary Women (ILEX)
Investigation of the Effects of Different Types of Exercise on Irisin, Leptin, and Ghrelin Levels in Sedentary Women
Aperçu de l'étude
Statut
Les conditions
Description détaillée
This interventional study is designed to investigate and compare the acute effects of aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT) on irisin, leptin, and ghrelin levels in sedentary women. A total of 20 sedentary women will participate in the study.
Participants will complete three different exercise conditions: aerobic exercise, anaerobic exercise, and HIIT. Irisin, leptin, and ghrelin levels will be evaluated in relation to each exercise condition to determine acute exercise-induced hormonal responses. The study will compare changes in these biomarkers across the three exercise modalities to determine whether the hormonal responses differ according to exercise type.
The study is intended to provide a better understanding of the acute endocrine and metabolic responses to exercise modalities with different physiological demands in sedentary women, with particular emphasis on irisin, leptin, and ghrelin.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Özgür EKEN, PhD
- Numéro de téléphone: +905532132795
- E-mail: ozgur.eken@inonu.edu.tr
Lieux d'étude
-
-
Karabük Province
-
Karabük, Karabük Province, Turquie (Türkiye)
- Exercise Physiology Laboratory, Faculty of Sport Sciences, Karabuk University
-
Contact:
- Musa ŞAHİN, PhD
- Numéro de téléphone: +905549755058
- E-mail: musasahin@karabuk.edu.tr
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria: Female participants Sedentary individuals Voluntary participation in the study Ability and willingness to complete the planned exercise sessions
Exclusion Criteria: Inability to participate in the planned exercise sessions Withdrawal of consent or unwillingness to continue participation
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Multiple Exercise Modalities
Participants in this arm will complete three different exercise conditions in separate sessions: aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT).
Irisin, leptin, and ghrelin levels will be assessed in relation to each exercise condition to evaluate and compare acute hormonal responses across the three exercise modalities.
|
Participants will complete an aerobic exercise session as one of the three exercise conditions.
Irisin, leptin, and ghrelin levels will be assessed in relation to the exercise session to determine the acute hormonal response to aerobic exercise.
Participants will complete an anaerobic exercise session as one of the three exercise conditions.
Irisin, leptin, and ghrelin levels will be assessed in relation to the exercise session to determine the acute hormonal response to anaerobic exercise.
Participants will complete a high-intensity interval training (HIIT) session as one of the three exercise conditions.
Irisin, leptin, and ghrelin levels will be assessed in relation to the exercise session to determine the acute hormonal response to HIIT.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Irisin Level
Délai: Pre-exercise and immediately post-exercise during each exercise session
|
Irisin levels will be assessed in relation to each exercise condition to determine the change in circulating irisin levels associated with aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT)
|
Pre-exercise and immediately post-exercise during each exercise session
|
|
Change in Leptin Level
Délai: Pre-exercise and immediately post-exercise during each exercise session
|
Leptin levels will be assessed in relation to each exercise condition to determine the change in circulating leptin levels associated with aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT).
|
Pre-exercise and immediately post-exercise during each exercise session
|
|
Change in Ghrelin Level
Délai: Pre-exercise and immediately post-exercise during each exercise session
|
Ghrelin levels will be assessed in relation to each exercise condition to determine the change in circulating ghrelin levels associated with aerobic exercise, anaerobic exercise, and high-intensity interval training (HIIT).
|
Pre-exercise and immediately post-exercise during each exercise session
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IRISIN-LEPTIN-2026-248
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .